HIGHLIGHTS
SUMMARY
(Green et_al, 2013; Marshall et_al, 2020). (Burke et_al, 2013; Committee on Bioethics Committee on Genetics ACMG Genomics SocialEthical and Legal Issues Committee, 2013; Ross et_al, 2013; Clayton et_al, 2014; Murray et_al, 2018). While it might seem straightforward to plan for offering panel testing to patients as they reach the "age of majority" (18 years old in the United_States, when individuals are granted full legal and decision-making capacity; also, the age at which most can consent to medical care), various trade-offs may make implementation later in adulthood preferable. (Goldberg et_al, 2011; Sjouke et_al . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.